SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013693
Filing Date
2024-04-29
Accepted
2024-04-29 16:15:25
Documents
7
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A gnpx20240418_def14a.htm DEF 14A 537900
2 comppaidvsnetloss800.jpg GRAPHIC 87007
3 comppaidvstsr800.jpg GRAPHIC 90007
4 image1.jpg GRAPHIC 8709
5 image2.jpg GRAPHIC 2293
6 prox_page1.jpg GRAPHIC 253091
7 prox_page2.jpg GRAPHIC 152678
  Complete submission text file 0001437749-24-013693.txt   1356574
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38244 | Film No.: 24890970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)